NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

Search

Roche Holding AG

Aperta

SettoreSettore sanitario

278 -0.14

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

276.4

Massimo

280

Metriche Chiave

By Trading Economics

Entrata

-4.2B

2B

Vendite

-109M

31B

P/E

Media del settore

26.874

50.291

Rendimento da dividendi

3.5

Margine di Profitto

6.588

Dipendenti

103,249

EBITDA

-4.6B

6B

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

3.50%

2.40%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-11B

208B

Apertura precedente

278.14

Chiusura precedente

278

Notizie sul Sentiment di mercato

By Acuity

22%

78%

45 / 380 Classifica in Healthcare

Roche Holding AG Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 giu 2025, 08:25 UTC

Acquisizioni, Fusioni, Takeovers

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12 mag 2025, 02:16 UTC

I principali Market Mover

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 apr 2025, 07:30 UTC

Utili

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 apr 2025, 05:31 UTC

Utili

Roche Sales Rise Boosted By Key Drugs

9 apr 2025, 09:39 UTC

I principali Market Mover

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mar 2025, 09:23 UTC

I principali Market Mover

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 gen 2025, 09:36 UTC

Utili

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 gen 2025, 06:32 UTC

Utili

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

16 giu 2025, 08:55 UTC

Azioni calde

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3 giu 2025, 07:51 UTC

Discorsi di Mercato

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21 mag 2025, 07:20 UTC

Discorsi di Mercato

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2 mag 2025, 06:25 UTC

Discorsi di Mercato
Utili

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 apr 2025, 09:39 UTC

Discorsi di Mercato
Utili

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 apr 2025, 09:24 UTC

Discorsi di Mercato
Utili

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 apr 2025, 09:18 UTC

Discorsi di Mercato
Utili

Roche's Results Are Solid -- Market Talk

24 apr 2025, 05:16 UTC

Notizie principali

Roche Sales Rise, Boosted By Key Drugs

22 apr 2025, 10:51 UTC

Notizie principali

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 apr 2025, 09:55 UTC

Discorsi di Mercato

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 apr 2025, 10:03 UTC

Discorsi di Mercato
Utili

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 apr 2025, 07:23 UTC

Discorsi di Mercato

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 apr 2025, 08:41 UTC

Discorsi di Mercato

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 apr 2025, 07:51 UTC

Discorsi di Mercato

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mar 2025, 09:31 UTC

Azioni calde

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mar 2025, 07:46 UTC

Discorsi di Mercato

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mar 2025, 16:34 UTC

Notizie principali

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mar 2025, 08:51 UTC

Discorsi di Mercato

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mar 2025, 08:18 UTC

Discorsi di Mercato

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 feb 2025, 11:43 UTC

Discorsi di Mercato

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 gen 2025, 07:56 UTC

Discorsi di Mercato
Utili

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 gen 2025, 06:04 UTC

Utili

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

Confronto tra pari

Modifica del prezzo

Roche Holding AG Previsione

Sentiment

By Acuity

45 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.